E-DRUG: Invitation to information sharing webinar on COVID-19 therapeutics
---------------------------------------------------------------------------
Optimizing evidence and access for COVID-19 therapeutics
Information sharing webinar organized by WHO in collaboration with Wellcome Trust and Unitaid 18 December 2020, 12:00-15:00 CET
Event registration: online form<https://who.zoom.us/webinar/register/WN_6hS5yKNSTtiHYBr76SoNcQ>
As of 8 December 2020, there were almost 70 million reported cases of COVID-19. The pandemic has so far claimed more than 1.5 million lives and many areas of the world are experiencing a resurgence in cases.
Increasingly, there are reports of patients suffering from prolonged symptoms and, in some cases, multi-system complications. Systemic corticosteroids are the only class of medicines to demonstrate some benefits, saving the lives of about one-third of patients with severe or critical disease in a large clinical trial and as yet, there is no proven therapy for patients with mild or moderate disease. Thus finding effective, safe, affordable, and accessible therapeutics to reduce mortality and morbidity remains an urgent priority.
The webinar will explain how WHO and partners are working towards access to COVID-19 therapeutics, including the work carried out by the Access to COVID-19 Tools Accelerator (ACT-A) Therapeutics Pillar, led by Unitaid and the Wellcome Trust. The webinar will cover end-to-end issues from the research and development landscape to getting products into countries.
Queries concerning the webinar can be addressed to hps@who.int<mailto:hps@who.int>.
Deirdre Dimancesco
Technical Officer
Health Products and Standards
Access to Medicines and Health Products
World Health Organization
Geneva, Switzerland
"DIMANCESCO, Deirdre" <dimancescod@who.int>